These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35466182)

  • 1. Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy.
    Sterner RC; Rose WN
    Hematol Rep; 2022 Apr; 14(2):119-125. PubMed ID: 35466182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of thrombotic microangiopathies in multiple myeloma.
    Portuguese AJ; Gleber C; Passero FC; Lipe B
    Leuk Res; 2019 Oct; 85():106195. PubMed ID: 31404728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab.
    Raufi AG; Scott S; Darwish O; Harley K; Kahlon K; Desai S; Lu Y; Tran MH
    Hematol Rep; 2016 Sep; 8(3):6625. PubMed ID: 27781079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management.
    Mazzierli T; Allegretta F; Maffini E; Allinovi M
    Front Pharmacol; 2022; 13():1088031. PubMed ID: 36699080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report.
    Mousseaux C; Joly BS; Mohamadou I; Arrestier R; Hertig A; Rafat C
    BMC Nephrol; 2020 May; 21(1):204. PubMed ID: 32471388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic Microangiopathy Secondary to Systemic Sclerosis with Severe Complement Activation Not Responsive to Eculizumab: A Case Report.
    Nakamura M; Abe T; Ochiai H
    Am J Case Rep; 2022 Jun; 23():e936116. PubMed ID: 35671252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study.
    Tekgündüz E; Yılmaz M; Erkurt MA; Kiki I; Kaya AH; Kaynar L; Alacacioglu I; Cetin G; Ozarslan I; Kuku I; Sincan G; Salim O; Namdaroglu S; Karakus A; Karakus V; Altuntas F; Sari I; Ozet G; Aydogdu I; Okan V; Kaya E; Yildirim R; Yildizhan E; Ozgur G; Ozcebe OI; Payzin B; Akpinar S; Demirkan F
    Transfus Apher Sci; 2018 Feb; 57(1):27-30. PubMed ID: 29503132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy and indications for therapeutic plasma exchange.
    Adamski J
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):444-9. PubMed ID: 25696892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange in thrombotic microangiopathies (TMAs) other than thrombotic thrombocytopenic purpura (TTP).
    Winters JL
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):632-638. PubMed ID: 29222314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab-Associated Thrombotic Microangiopathy Treated with Eculizumab: A Case Report.
    Padilha WSC; Cesar BN; Pacheco ST; De Sousa AA; Ledesma FL; Malheiros DMAC; Teixeira MCA
    Am J Case Rep; 2023 Aug; 24():e940906. PubMed ID: 37644709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case Report of Quinine-Induced Thrombotic Microangiopathy Successfully Treated With Eculizumab.
    Ng JY; Lenton D; Kerridge I; Wong C
    J Investig Med High Impact Case Rep; 2024; 12():23247096241235617. PubMed ID: 38477293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review.
    McFarlane PA; Bitzan M; Broome C; Baran D; Garland J; Girard LP; Grewal K; Lapeyraque AL; Patriquin CJ; Pavenski K; Licht C
    Can J Kidney Health Dis; 2021; 8():20543581211008707. PubMed ID: 33996107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition.
    Catanese L; Link K; Rupprecht H
    BMC Nephrol; 2023 Jun; 24(1):179. PubMed ID: 37337151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case off TTP temporally associated with cocaine use: Implications for treatment of suspected DITMA.
    Regner SR; Lerfald N
    J Clin Apher; 2019 Aug; 34(4):510-512. PubMed ID: 30776151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
    de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP
    Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism-mediated thrombotic microangiopathy and B12.
    Goubran H; Ragab G; Sabry W
    Vitam Horm; 2022; 119():441-455. PubMed ID: 35337630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-Associated Thrombotic Microangiopathy.
    Aklilu AM; Shirali AC
    Kidney360; 2023 Mar; 4(3):409-422. PubMed ID: 36706238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
    Mehmood T; Taylor M; Winters JL
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.